Will This Diet Device Be a Blockbuster?

The latest Bloomberg Businessweek describes an implantable device called Abiliti that could be a boon for people who are overweight. It sends electrical pulses to the stomach and makes people feel full.

The company making this, IntraPace, is privately held, but investors include Boston Scientific (BSX) and Johnson & Johnson (JNJ).

BSX Chart

BSX data by YCharts

It would be too early to call this so-called “gastric pacemaker” the cure for obesity. While approved in Europe, Alibiti doesn’t yet have any long-term studies available that show how well it works. But if you're looking for investment opportunities presented by our unfortunate obesity epidemic, keep this one in your back pocket and check out this YCharts story for other ideas.

From the editors of YCharts.YCharts Pro Investor Service includes professional stock charts, stock ratings and portfolio strategies.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.